Belpointe Asset Management’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

Belpointe Asset Management’s Portfolio CALT Stock Details CALT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$2.42K	Hold
2022 Q4	$1.72K	Buy